MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma
Received date: 12 May 2015
Accepted date: 11 Jun 2015
Published date: 11 Sep 2015
Copyright
MicroRNAs (miRNAs) are a type of small non-coding RNAs that are often play important roles in carcinogenesis, but the carcinogenic mechanism of miRNAs is still unclear. This study will investigate the function and the mechanism of miR-638 in carcinoma (GC). The expression of miR-638 in GC and the DNA copy number of miR- 638 were detected by real-time PCR. The effect of miR-638 on cell proliferation was measured by counting kit-8 assay. Different assays, including bioinformatics algorithms (TargetScan and miRanda), luciferase report assay and Western blotting, were used to identify the target gene of miR-638 in GC. The expression of miR-638 target gene in clinical CRC tissues was also validated by immunohistochemical assay. From this research, we found that miR-638 was downregulated in GC tissues compared with corresponding noncancerous tissues (NCTs), and theDNAcopy numberof miR-638waslower in GC than NCTs, which may induce the corresponding downregulation of miR-638 in GC. Ectopic expression of miR-638 inhibited GC cell growth in vitro. Subsequently, we identified that PLD1 is the target gene of miR-638 in GC, and silencing PLD1 expression phenocopied the inhibitory effect of miR-638 on GC cell proliferation. Furthermore, we observed that PLD1 was overexpressed in GC tissues, and high expression of PLD1 in GC predicted poor overall survival. In summary, we revealed that miR- 638 functions as a tumor suppressor in GC through inhibiting PLD1.
Key words： gastric cancer; miR-638; cell proliferation; PLD1
Jiwei Zhang , Zehua Bian , Jialiang Zhou , Mingxu Song , Zhihui Liu , Yuyang Feng , Li Zhe , Binbin Zhang , Yuan Yin , Zhaohui Huang . MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma[J]. Protein & Cell, 2015 , 6(9) : 680 -688 . DOI: 10.1007/s13238-015-0187-8
| 1 |
Bartel DP(2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215―233
|
| 2 |
Cho WC(2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273―1281
|
| 3 |
Cidon EU, Ellis SG, Inam Y, Adeleke S, Zarif S, Geldart T (2013) Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers 5: 64―91
|
| 4 |
Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, Shen ZY, Cao H, Lu YY, Fang JY(2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 6: e25872
|
| 5 |
Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D
|
| 6 |
Esquela-Kerscher A, Slack FJ(2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6: 259―269
|
| 7 |
Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118―126
|
| 8 |
Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X, Du X (2011) MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 71: 2582―2589
|
| 9 |
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69―90
|
| 10 |
Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, Olaru AV, Yang J, David S, Hamilton JP
|
| 11 |
Kang DW, Hwang WC, Park MH, Ko GH, Ha WS, Kim KS, Lee YC, Choi KY, Min DS(2013) Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFkappaB and suppresses invasion of gastric cancer cells. Oncogene 32: 3531―3542
|
| 12 |
Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M
|
| 13 |
Li D, Wang Q, Liu C, Duan H, Zeng X, Zhang B, Li X, Zhao J, Tang S, Li Z
|
| 14 |
Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu KC, Nie YZ
|
| 15 |
Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H (2012) Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 130: 2077―2087
|
| 16 |
Ma K, Pan X, Fan P, He Y, Gu J, Wang W, Zhang T, Li Z, Luo X (2014) Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells. Mol Cancer 13: 118
|
| 17 |
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY
|
| 18 |
Shrestha S, Hsu SD, Huang WY, Huang HY, Chen W, Weng SL, Huang HD (2014) A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med 3(4): 878―888
|
| 19 |
Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, Zhou L, Hu Y, Wang Q, Ni S
|
| 20 |
Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE (2011) MicroRNA control of invasion and metastasis pathways. Front Genet 2: 58
|
| 21 |
Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T
|
| 22 |
Wang TL, Maierhofer C, Speicher MR, Lengauer C, Vogelstein B, Kinzler KW, Velculescu VE (2002) Digital karyotyping. Proc Natl Acad Sci USA 99: 16156―16161
|
| 23 |
Wang Q, Huang Z, Guo W, Ni S, Xiao X, Wang L, Huang D, Tan C, Xu Q, Zha R
|
| 24 |
Xia Y, Wu Y, Liu B, Wang P, Chen Y (2014) Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC. FEBS Lett 588: 2238―2245
|
| 25 |
Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S (2013) MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 335: 219―224
|
| 26 |
Yin Y, Zhang B, Wang W, Fei B, Quan C, Zhang J, Song M, Bian Z, Wang Q, Ni S
|
| 27 |
Zhang Y, Frohman MA (2014) Cellular and physiological roles for phospholipase D1 in cancer. J Biol Chem 289: 22567―22574
|
| 28 |
Zhang J, Fei B, Wang Q, Song M, Yin Y, Zhang B, Ni S, Guo W, Bian Z, Quan C
|
| 29 |
Zhang B, Yin Y, Hu Y, Zhang J, Bian Z, Song M, Hua D, Huang Z (2015) MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A. Med Oncol 32: 331
|
/
| 〈 |
|
〉 |